Day: March 31, 2021

Pompano Beach, FL, March 31, 2021 (GLOBE NEWSWIRE) — Brownie’s Marine Group, Inc. (OTCQB: BWMG), a leading developer, manufacturer and distributor of tankless dive equipment and high-pressure air and industrial compressors in the marine industry, today announced results for the fiscal fourth quarter and twelve months ending December 31, 2020. Chris Constable, CEO of Brownie’s Marine Group, Inc. stated, “Brownie’s Marine Group had a break-out year in 2020 achieving an Adjusted Net Income profit, in addition to overall revenue increasing 53% year over year. The strong performance can be attributed in part to the team at BLU3, led by Blake Carmichael, who had a fantastic fourth quarter holiday season with a 35% Q4 revenue increase year over year. The BLU3 division continues to grow sales of our BLU3 Nemo product, which has strong momentum...

Copenhagen, March 31, 2021 (GLOBE NEWSWIRE) —The AI-based media intelligence company Hypefactors, providing users with a real-time overview of global and local media mentions and reputation for companies/organizations, brands, competitors, industries, and trends, is pleased to announce a combination of financial agreements that will strengthen the company’s capital structure and balance sheet. Vaekstfonden (the Danish state’s investment fund) has approved Hypefactors for a so-called ‘investor loan’ of a total of DKK 4 million – on attractive conditions. This in combination with a similar invested amount in a private placement from a group of investors, including the recently appointed CFO Michael Østerlund Madsen, the company’s second-largest shareholder Jan Werner and another early shareholder Augustenborg Holding ApS. The...

GRAND RAPIDS, Mich., March 31, 2021 (GLOBE NEWSWIRE) — UFP Industries, Inc.Nasdaq: UFPIwww.ufpi.com Conference Call to Discuss Q1 2021 Hosted by:Matthew J. Missad, Chief Executive OfficerMichael Cole, Chief Financial Officer Press ReleaseWednesday, April 21, 2021 (after market) Conference CallWednesday, April 21, 20214:30 p.m. ET * Webcast of Conference Call *www.ufpi.comClick on Investor Relations, then Webcast U.S. dial-in number: 866-518-4547International dial-in: 213-660-0879Chairperson: Matthew J. Missad Conference ID6679712 Conference Call Replay (Encore) available through Saturday, April 24, 2021855-859-2056, 404-537-3406, or 800-585-8367 For more information, please contact:Dick Gauthier, Vice President of Business Outreach, 616-365-1555

FINANCIAL INFORMATION 2020Including the Consolidated financial statements and Report of the Réviseur d´Entreprises for the financial year ended as at 31 December 2020 AttachmentCPI_FIM_MR_2020_combined

InterCure, dba Canndoc, Announces Record-Breaking Q4 Results with Positive EBITDA and Cash Flow InterCure Acquires Four New Medical Cannabis Pharmacies and Increases 2021 Target to 10 Retail Locations Canndoc Successfully Launches First Product Line of California Genetic Strains Grown in Israel TORONTO, March 31, 2021 (GLOBE NEWSWIRE) — SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“SVX”) announced today that InterCure Ltd. (dba Canndoc) (TASE: INCR) (“InterCure”), Israel’s leading cannabis company and SVX’s intended target for its “Qualifying Transaction” (the “Transaction”), has reported its fourth quarter and full-year 2020 results (the “InterCure Press Release”). InterCure has announced that it accelerated its growth and distribution footprint in Israel by expanding its retail footprint with the acquisition...

DELRAY BEACH, Fla., March 31, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today provided key takeaways from its conference call reporting on the topline results from its Phase 2b OPTION 2 clinical trial investigating MS1819 in cystic fibrosis (CF) patients with exocrine pancreatic insufficiency (EPI). The conference call, held on March 31, 2021, at 4:30 p.m. ET, featured James Sapirstein, President, CEO and Chairman of AzurRx, and Dr. James Pennington, Chief Medical Officer, discussing the recently completed OPTION 2 study, and the company’s plans to develop an optimized formulation of MS1819 for ongoing clinical investigation. OPTION 2...

ATLANTA, March 31, 2021 (GLOBE NEWSWIRE) — Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” “the Company,” “we,” “our” or “us”), a technology-enabled financial services company that assists financial institutions in offering credit to millions of everyday Americans, today announced its financial results for the year ended December 31, 2020. The Company also announced the filing of its Annual Report on Form 10-K with the Securities and Exchange Commission. Financial and Operating Highlights (all comparisons to the prior period unless otherwise specified) 2020 HighlightsNet income attributable to common shareholders increased 204.7% to $77.1 million, or $5.32 per basic common share Total operating revenue increased $216.4 million, or 63.0%, to $560.0 million Managed receivables(1) associated with our Credit and Other...

ASHBURN, Va., March 31, 2021 (GLOBE NEWSWIRE) — Telos® Corporation (“Telos”) (Nasdaq: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, announced today the launch of a proposed follow-on public offering (the “Offering”), including a secondary public offering by certain existing stockholders of Telos (the “Selling Stockholders”). Telos will not receive any proceeds from the shares of common stock sold by the Selling Stockholders. B. Riley Securities, BMO Capital Markets, and Needham & Company are acting as joint bookrunners for the Offering. D.A. Davidson & Co., Wedbush Securities, Colliers Securities LLC, Northland Capital Markets, and MKM Partners will serve as co-managers for the Offering. Telos and certain of the Selling Stockholders have...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, March 31, 2021 (GLOBE NEWSWIRE) — Bayshore, the TSX Venture Exchange (TSX: BHS) listed technology focused oil and gas company, announces resignation of Chief Financial Officer. Bayshore announces that Lance Mierendorf, CPA, will be vacating the position of Chief Financial Officer effective March 31, 2021. Peter Ho, Bayshore’s President and CEO will assume the CFO duties on an interim basis. Mr. Mierendorf will consult on a short-term, part-time basis to Bayshore to ensure an orderly CFO transition. The Board would like to thank Lance for his valuable contributions during his tenure at the Company. Bayshore is currently undertaking a process of evaluating strategic alternatives to recapitalize the Company and gain access to...